Investigational Drug Information for CRN00808
✉ Email this page to a colleague
What is the development status for investigational drug CRN00808?
CRN00808 is an investigational drug.
There have been 7 clinical trials for CRN00808.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 17th 2021.
The most common disease conditions in clinical trials are Acromegaly and [disabled in preview]. The leading clinical trial sponsors are Crinetics Pharmaceuticals Inc. and [disabled in preview].
There are two US patents protecting this investigational drug and twenty-eight international patents.
Summary for CRN00808
| US Patents | 2 |
| International Patents | 28 |
| US Patent Applications | 18 |
| WIPO Patent Applications | 6 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2021-12-17) |
| Vendors | 23 |
Recent Clinical Trials for CRN00808
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2) | Crinetics Pharmaceuticals Inc. | Phase 3 |
| A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly | Crinetics Pharmaceuticals Inc. | Phase 3 |
| Mass Balance and Pharmacokinetics of [14C]-CRN00808 in Healthy Volunteers | Crinetics Pharmaceuticals Inc. | Phase 1 |
Clinical Trial Summary for CRN00808
Top disease conditions for CRN00808
Top clinical trial sponsors for CRN00808
US Patents for CRN00808
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| CRN00808 | ⤷ Sign Up | Somatostatin modulators and uses thereof | CRINETICS PHARMACEUTICALS, INC. (San Diego, CA) | ⤷ Sign Up |
| CRN00808 | ⤷ Sign Up | Somatostatin modulators and uses thereof | CRINETICS PHARMACEUTICALS, INC. (San Diego, CA) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for CRN00808
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| CRN00808 | Australia | AU2017296392 | 2036-07-14 | ⤷ Sign Up |
| CRN00808 | Australia | AU2020277122 | 2036-07-14 | ⤷ Sign Up |
| CRN00808 | Brazil | BR112019000692 | 2036-07-14 | ⤷ Sign Up |
| CRN00808 | Canada | CA3030423 | 2036-07-14 | ⤷ Sign Up |
| CRN00808 | China | CN109715612 | 2036-07-14 | ⤷ Sign Up |
| CRN00808 | China | CN115557929 | 2036-07-14 | ⤷ Sign Up |
| CRN00808 | Denmark | DK3484865 | 2036-07-14 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
